J&J Sees China Center As Key To Asian Partnerships
This article was originally published in PharmAsia News
Tapping key external partners including the government, industry and academic partners in China is high on the agenda as Johnson & Johnson opens its first Asia Innovation Center.
You may also be interested in...
Throughout 2020, China’s drive to introduce more and newer drugs to the market did not slow but was rather accelerated by the COVID-19 pandemic. But can people afford them?
From bringing innovative new drugs to global markets, to record-setting fundraisings and initial public offerings, five trends are emerging in China's health sector that are worth closely watching in 2021.
One year after the first cases of a novel coronavirus emerged in Wuhan, a team from the World Health Organization has arrived in the city to investigate its origin. Meanwhile, mixed results are reported for some of the leading Chinese vaccines being developed to fight the pandemic still wreaking global havoc.